Methyldopa and Psoriasis - a phase IV clinical study of FDA data

Summary:

Psoriasis is reported as a side effect among people who take Methyldopa (methyldopa), especially for people who are female, 40-49 old, also take Enbrel, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Psoriasis when taking Methyldopa. It is created by eHealthMe based on reports of 6,345 people who have side effects when taking Methyldopa from the FDA, and is updated regularly.

What is Methyldopa?

Methyldopa has active ingredients of methyldopa. It is often used in high blood pressure. eHealthMe is studying from 6,475 Methyldopa users. Check the latest studies of Methyldopa.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,477 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.



On Jul, 17, 2026

6,345 people reported to have side effects when taking Methyldopa.
Among them, 14 people (0.22%) have Psoriasis.

Could Methyldopa cause Psoriasis?

Among these 14 people:

What is the gender of people who have Psoriasis when taking Methyldopa? *

  • female: 92.86 %
  • male: 7.14 %

What is the age of people who have Psoriasis when taking Methyldopa? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 11.11 %
  • 40-49: 66.67 %
  • 50-59: 11.11 %
  • 60+: 11.11 %

What are other drugs people take besides Methyldopa? *

  1. Enbrel: 10 people, 71.43%
  2. Norvasc: 6 people, 42.86%
  3. Cellcept: 5 people, 35.71%
  4. Humira: 2 people, 14.29%
  5. Benicar: 2 people, 14.29%
  6. Fish Oil: 2 people, 14.29%
  7. Prednisone: 2 people, 14.29%
  8. Zolpidem: 1 person, 7.14%
  9. Lansoprazole: 1 person, 7.14%
  10. Halobetasol Propionate: 1 person, 7.14%

What are other side effects people have besides Psoriasis? *

  1. Gestational Diabetes (diabetes in pregnancy): 6 people, 42.86%
  2. Incision Site Haematoma (small sac of blood near a surgical site): 4 people, 28.57%
  3. Suppressed Lactation: 4 people, 28.57%
  4. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 21.43%
  5. Foetal Malpresentation (abnormal positions of the vertex of the fetal head relative to the maternal pelvis): 2 people, 14.29%
  6. Cephalo-Pelvic Disproportion (situation in which baby head of body is too large to deliver): 2 people, 14.29%
  7. Nasopharyngitis (inflammation of the nasopharynx): 2 people, 14.29%
  8. Nosebleed (bleeding from nose): 2 people, 14.29%
  9. Heavy Or Prolong Menstrual Bleeding: 1 person, 7.14%
  10. Headache (pain in head): 1 person, 7.14%

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 21.43%
  2. Type 2 Diabetes: 1 person, 7.14%
  3. Stress And Anxiety: 1 person, 7.14%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 7.14%
  6. Nausea (feeling of having an urge to vomit): 1 person, 7.14%
  7. High Blood Cholesterol: 1 person, 7.14%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%
  9. Dysmenorrhea (painful menstruation): 1 person, 7.14%
  10. Depression: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Methyldopa and have Psoriasis?

- Check whether Psoriasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methyldopa:

Psoriasis treatments and more:

How severe was Psoriasis and when was it recovered:

Expand to all the drugs that have ingredients of methyldopa:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methyldopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psoriasis:

Browse all the conditions that are associated with Psoriasis:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methyldopa (the active ingredients of Methyldopa) and Methyldopa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: